Hims & Hers is expanding access to Eli Lilly's branded weight loss drug Zepbound and diabetes drug Mounjaro as well as generics of Novo Nordisk's ... said it would offer generic liraglutide ...

People are buying semaglutide and tirzepatide, the key ingredients in Ozempic and Zepbound, from unconventional sources. Doctors have safety concerns.

Norlys TV customers will see their monthly bills rise by up to 20 DKK starting July 1st. According to the company, this ...

Easter in Denmark will be mostly without sun, but, with a bit of luck, also without heavy rain—at least most of the time. The ...

Lilly is also sending out about 50 cease-and-desist letters to compounders and telehealth ... Lilly competitor Novo Nordisk (NVO) has also experienced shortages of its GLP-1, semaglutide, marketed ...

S&P 500 E-Mini futures are up +0.98%, andJune Nasdaq 100 E-Mini futures are up +1.05% this morning, signaling a rebound from yesterday’s sell-off on Wall Street, while inve ...

In the meantime, have a read of Emma Hanrahan’s piece on the Kingspan chief receiving backing from investor advisory firm ...

Novo Nordisk (NYSE:NVO) stock has experienced a significant decline, dropping 35% from over $90 in early March to around $58 ...

Novo Nordisk scored a legal win against compounders of its blockbuster GLP-1 drugs. But it may not end the copycats.

Novo Nordisk (NYSE: NVO), the Danish drugmaker that's been riding high ever since it began putting out Ozempic and Wegovy GLP-1 injectables for treatment of diabetes and weight loss, got another ...

Patients flocked to those Ozempic, Wegovy copycats when the branded drugs were in short supply, or if they didn’t have ...